Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRSS3P4 is a **pseudogene** related to the PRSS3 gene family but does not encode a functional protein or exert known biological or pharmacological effects. Pseudogenes arise when a gene becomes inactivated by mutation or loss of regulatory elements, retaining sequence similarity to the functional gene but lacking its enzymatic or biological activity. The functional PRSS3 gene encodes a digestive serine protease (trypsin-4/mesotrypsin) involved in proteolysis in the pancreas and brain, but there is no evidence that PRSS3P4 itself is expressed, translated, or plays any direct role in physiology or disease[3][4][5].\n\n**Key distinctions:**\n- PRSS3P4 should not be confused with **PRSS3** (mesotrypsin/trypsin-4), which is a serine protease with disease associations[1][2][3][4][5].\n- As a pseudogene, PRSS3P4 does not have *known drug interactions*, *measurable activity*, or *utility as a biomarker or target*.\n\nIf you are seeking information on the functional serine protease, refer to protease, serine 3 (PRSS3), not the pseudogene PRSS3P4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRSS3 pseudogene 4 (PRSS3P4).